Hyderabad Institute Of Oncology Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 Hyderabad, Telangana, India Active
Last Updated:
About Hyderabad Institute Of Oncology Private Limited

Hyderabad Institute Of Oncology Private Limited, a active private limited company, was established on 01 January 2010 in Hyderabad, Telangana, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85110TG2010PTC066521. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹24.99 Cr and a paid-up capital of ₹9.13 Cr.

It upholds a compliant status. Employing 1,314 professional, Its leadership includes Nagavardhanamma Parvathaneni (Director), Arjun Saigal (Director), Mohan Vamsy Chigurupati (Managing Director). Past directors included Renu Challu, Nagavardhanamma Parvathaneni, Rambabu Ravi. It holds ₹325.33 Cr open charges and ₹54.81 Cr settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at H.No:8-2-293/82/L/276A, Mla Colony Road No:12, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110TG2010PTC066521

  • Registration Number

    066521

  • Incorporation Date

    01 January 2010

  • Authorized Capital

    ₹24.99 Cr

  • Paid-Up Capital

    ₹9.13 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 24.99 Cr
  • Paid Up Capital ₹ 9.13 Cr
  • Company Age 16 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 325.33 Cr
  • Satisfied Charges ₹ 54.81 Cr
  • Revenue Growth **** 46.00%
  • Profit Growth **** -52.67%
  • Ebitda **** 289.69%
  • Net Worth -3.95%
  • Total Assets **** 63.42%
Company report

Hyderabad Institute Of Oncology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hyderabad Institute Of Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hyderabad Institute Of Oncology Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagavardhanamma Parvathaneni Director 14 Mar 2011 Current
Arjun Saigal Director 15 Jun 2024 Current
Mohan Vamsy Chigurupati Managing Director 27 Mar 2010 Current
Padmaja Chigurupati Director 27 Mar 2010 Current
Jasthi Krishna Kishore Additional Director 22 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2024 Past
Pramod Abcsdd Additional Director 09 Sep 2011 Past
Pramod Abcsdd Director 30 Mar 2010 Past
Pramod Abcsdd Director 27 Mar 2010 Past
Pramod Abcsdd Director 16 Mar 2020 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hyderabad Institute Of Oncology.

Hyderabad Institute Of Oncology Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 46% increase. The company also saw a substantial fall in profitability, with a 52.67% decrease in profit. The company's net worth dipped by a decrease of 3.95%.

Hyderabad Institute Of Oncology revenue growth over time
Hyderabad Institute Of Oncology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
46.00%
*******
*******
*******
*******
Revenue from Operations
*******
49.46%
*******
*******
*******
*******
Total Assets
*******
63.42%
*******
*******
*******
*******
Profit or Loss
*******
-52.67%
*******
*******
*******
*******
Net Worth
*******
-3.95%
*******
*******
*******
*******
EBITDA
*******
289.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hyderabad Institute Of Oncology?

In 2024, Hyderabad Institute Of Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,253,268,706.20

Satisfied Charges

₹548,110,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 172.81 Cr
  • Axis Bank Limited : 94.51 Cr
  • Others : 58.01 Cr
Latest Charge Details
Date Lender Amount Status
26 Sep 2025 Axis Bank Limited ₹1.16 Cr Open
26 Sep 2025 Axis Bank Limited ₹5.00 Cr Open
30 Sep 2024 Axis Bank Limited ₹6.11 Cr Open
30 Sep 2024 Axis Bank Limited ₹1.40 Cr Open
27 Sep 2024 Axis Bank Limited ₹70.76 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Hyderabad Institute Of Oncology?

Hyderabad Institute Of Oncology has a workforce of 1314 employees as of Nov 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hyderabad Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Institute Of Oncology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hyderabad Institute Of Oncology
Recent Activity within the Organization
  • Charges

    A charge with Axis Bank Limited amounted to Rs. 1.16 Cr with Charge ID 101164164 was registered on 26 Sep 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101160347 was registered on 26 Sep 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 67.86 Cr registered on 04 Jun 2018 with Charge ID 100182377 was modified on 04 Sep 2025. was completed.

  • Director Appointment

    Progress on Jasthi Krishna Kishore was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2025 & has been associated with this company since 6 months 11 days . was documented.

  • Charges

    A charge with Axis Bank Limited of Rs. 70.76 Cr registered on 27 Sep 2024 with Charge ID 100990238 was modified on 15 May 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Hyderabad Institute Of Oncology Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hyderabad Institute Of Oncology Private Limited?

The CIN of Hyderabad Institute Of Oncology Private Limited is U85110TG2010PTC066521.

Where is Hyderabad Institute Of Oncology Private Limited headquartered?

Hyderabad Institute Of Oncology Private Limited is headquartered at H.No:8-2-293/82/L/276A, Mla Colony Road No:12, Banjara Hills, Hyderabad, Telangana, 500034.

When was Hyderabad Institute Of Oncology Private Limited incorporated?

Hyderabad Institute Of Oncology Private Limited was incorporated on 01 January 2010.

Who are the current directors of Hyderabad Institute Of Oncology Private Limited?

The current directors of Hyderabad Institute Of Oncology Private Limited are

What is the primary industry of Hyderabad Institute Of Oncology Private Limited?

The primary industry of Hyderabad Institute Of Oncology Private Limited is Hospital And Medical Care.

Is Hyderabad Institute Of Oncology Private Limited a listed company?

Hyderabad Institute Of Oncology Private Limited is unlisted.

What is the capital structure of Hyderabad Institute Of Oncology Private Limited?

The authorized capital of Hyderabad Institute Of Oncology Private Limited is ₹24.99 Cr, and the paid-up capital is ₹9.13 Cr.

What is the compliance status of Hyderabad Institute Of Oncology Private Limited?

The compliance status of Hyderabad Institute Of Oncology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available